Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Survival Impact of Postoperative Whole-brain Radiotherapy and Systemic Chemotherapy After Surgical Resection of Brain Metastases

HIROMASA YOSHIOKA, TAKESHI OKUDA, MITSUGU FUJITA, TAKAYUKI NAKAO and JUN C. TAKAHASHI
Anticancer Research August 2024, 44 (8) 3663-3667; DOI: https://doi.org/10.21873/anticanres.17190
HIROMASA YOSHIOKA
1Department of Neurosurgery, Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI OKUDA
1Department of Neurosurgery, Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: okuda{at}med.kindai.ac.jp
MITSUGU FUJITA
2Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAYUKI NAKAO
1Department of Neurosurgery, Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUN C. TAKAHASHI
1Department of Neurosurgery, Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 8 3663-3667
DOI 
https://doi.org/10.21873/anticanres.17190
PMID 
39060067

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 21, 2024
  • Revision received June 12, 2024
  • Accepted June 13, 2024
  • Published online July 26, 2024.

Copyright & Usage 
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. HIROMASA YOSHIOKA1,
  2. TAKESHI OKUDA1⇑,
  3. MITSUGU FUJITA2,
  4. TAKAYUKI NAKAO1 and
  5. JUN C. TAKAHASHI1
  1. 1Department of Neurosurgery, Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  2. 2Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan
  1. Correspondence to: Dr. Takeshi Okuda, Department of Neurosurgery, Kindai University, Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan. Tel: +81 723660221 (EXT3547), Fax: +81 723656975, e-mail: okuda{at}med.kindai.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Survival Impact of Postoperative Whole-brain Radiotherapy and Systemic Chemotherapy After Surgical Resection of Brain Metastases
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Survival Impact of Postoperative Whole-brain Radiotherapy and Systemic Chemotherapy After Surgical Resection of Brain Metastases
HIROMASA YOSHIOKA, TAKESHI OKUDA, MITSUGU FUJITA, TAKAYUKI NAKAO, JUN C. TAKAHASHI
Anticancer Research Aug 2024, 44 (8) 3663-3667; DOI: 10.21873/anticanres.17190

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Survival Impact of Postoperative Whole-brain Radiotherapy and Systemic Chemotherapy After Surgical Resection of Brain Metastases
HIROMASA YOSHIOKA, TAKESHI OKUDA, MITSUGU FUJITA, TAKAYUKI NAKAO, JUN C. TAKAHASHI
Anticancer Research Aug 2024, 44 (8) 3663-3667; DOI: 10.21873/anticanres.17190
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Survival Then and Now in Patients With Surgically Resected Brain Metastasis: Major Improvement in Cases With Controlled Primary Tumor
  • Google Scholar

More in this TOC Section

  • Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
  • Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases
  • Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
Show more Clinical Studies

Keywords

  • brain metastases
  • surgical resection
  • prognostic factor
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire